In this review:
Deucravacitinib & acneiform eruptions
Upadacitinib: long-term safety in atopic dermatitis with CV risk
T helper cell polarisation in checkpoint blockade-related cutaneous toxicities
Pre-dupilumab infectious disease screening in Australia
Microplastic exposure & keratinocyte biology
Melanomas in patients with Asian ancestry
3D total body photography + AI for melanoma risk stratification
AI controversies in dermatology
Scientific evidence on isotretinoin controversies
Updates in sunscreen research
Please login below to download this issue (PDF)